Investor Relations

IR Home

IR Home

Recent News
9/17/18

Conformis to Receive $10.5 Million for Non-Exclusive License to Patient-Specific Instrument Patents for use with off-the-shelf knee implants BILLERICA, Mass. , Sept. 17, 2018 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit

8/2/18

BILLERICA, Mass. , Aug. 02, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy,

IR Contact  
Oksana Bradley
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com
 
Media Contacts  
Bill Berry
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Bberry@berrypr.com
 
Lynn Granito
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Lgranito@berrypr.com
Featured Reports
More information is coming soon.